Similar articles

• [Thrombolytic (fibrinolytic) agents for treatment of ischemic heart disease].

  Nagao K, Kanmatsuse K. Nagao K, et al. Nihon Rinsho. 2003 Apr;61 Suppl 4:641-6. Nihon Rinsho. 2003. PMID: 12735044 Review. Japanese. No abstract available.
• Hemorrhagic complications of thrombolytic therapy.

  Vujković Z, Racić D, Miljković S, Dajić V. Vujković Z, et al. Med Pregl. 2012 Jan-Feb;65(1-2):9-12. Med Pregl. 2012. PMID: 22452232
• [Intracranial hemorrhage following second thrombolytic treatment of myocardial reinfarction].

  Valentín Segura V, Valls Grima F, Broch Porcar MJ, Miralles Serrano L, Olivares Toledo D, Alvarez Cebrián F. Valentín Segura V, et al. Rev Esp Cardiol. 1994 Dec;47(12):836-8. Rev Esp Cardiol. 1994. PMID: 7855379 Spanish.
• Stroke associated with thrombolytic therapy for acute myocardial infarction.

  Sloan MA. Sloan MA. Heart Dis Stroke. 1992 Sep-Oct;1(5):287-94. Heart Dis Stroke. 1992. PMID: 1344119 Review. No abstract available.
• [Experience with the thrombolytic therapy of myocardial infarct].

  Gospodarenko AL, Ardashev VN, Tiurin VP, Chernetsov VA, Iakovlev VB, Vrublevskiĭ OIu, Makarenko AS, Sokolianskiĭ NV, Chernov SA, Kucherov VV, Davrent'eva TA. Gospodarenko AL, et al. Voen Med Zh. 1997 Nov;318(11):40-5. Voen Med Zh. 1997. PMID: 9461835 Russian. No abstract available.